Skip to content
Newsletter
Bullishmedium conviction · 3 yearsActive · reviewed today$KLAC$157.91Fri 30 Oct

KLA: the toll on getting every advanced chip right

By MenFem Editorial·Semiconductors — Equipment·6 November 2026·Methodology·
ai-infrastructuresemiconductorsequipment
The next review, the day it is written.
Share

Price since the call

$157.91+13.8% since opened

Entered at $138.80, the close on 6 Nov; last close 30 Oct. The grade comes from the falsifier, never this number.

What would prove this wrong · verbatim, as published

The reason for holding this stops being true if the demand turns: KLA's revenue falling year on year for two consecutive quarters. It also stops being true if the toll weakens: non-GAAP gross margin below 58% for two consecutive quarters.
  • leg 1 · Revenue down YoY two consecutive quarters · not read yet
  • leg 2 · Non-GAAP gross margin below 58% two consecutive quarters · not read yet

Scrub the call’s life

week ending 30 Oct · close 157.91 · +13.8% since openedNo review yet by this week.

The argument, taken apart

Turn it, hover a ring, a moon or a weight
One call, taken apart
Rings are the falsifier’s legs. Moons are the catalysts it named. Weights are its risks, longer for higher severity.
The claim

The highest-margin, steadiest part of chip equipment: every advanced chip has to be inspected and measured. Bullish; China is the risk.

What would make it wrong · 2 legs
  1. Leg 1 · Not read yet
    Revenue down YoY two consecutive quarters
    Not read at a review yet.
  2. Leg 2 · Not read yet
    Non-GAAP gross margin below 58% two consecutive quarters
    Not read at a review yet.
The window
6 Nov 2026 to 6 Nov 2029
0% gone · 1096 days left
The reviews
Not reviewed since it was published
Column = the claim, taller for more conviction · rings = falsifier legs, lit when firing · moons = catalysts · weights = risks, longer for higher severity
  • Leg 1, not read yet: Revenue down YoY two consecutive quarters
  • Leg 2, not read yet: Non-GAAP gross margin below 58% two consecutive quarters
  • December-quarter results (late Jan 2027)
  • US export rules
  • high severity: China and export controls
  • medium severity: Equipment cycle

The timeline · 1 entry · newest firstreviews · notes · moves · the book

  1. 6 Nov 2026
    Opened

    KLA: the toll on getting every advanced chip right

Key Points

  • FQ1 FY27 revenue $4.14B (+29% YoY, +13% QoQ); operating margin ~45%.
  • $4.0B of twelve-month free cash flow; $943M bought back in the quarter.
  • December guided to $4.7B.
  • China 34.5% of revenue, up from 26.2% a quarter earlier.

Making an advanced chip takes hundreds of steps, and every one has to be checked. KLA makes most of the inspection and measurement tools that do the checking, and as chips get smaller, stack higher and add advanced packaging for AI, there is more to check. Its fiscal first quarter of 2027 showed what that is worth: revenue of $4.14B, up 29% on the year and 13% on the quarter, an operating margin of about 45%, and $4.0B of free cash flow over twelve months, with $943M of buybacks in the quarter. It guided the December quarter to $4.7B, roughly 14% higher again. Process control is also the steadiest part of chip equipment, because it scales with the complexity of every node rather than with new capacity alone. Conviction is MEDIUM because of China: 34.5% of revenue in the quarter, up from 26.2% the quarter before, and exposed to export rules that have cut KLA's sales before. Inventory is rising and the customer base is concentrated. It sits with MenFem's ASML and TSMC calls as a chokepoint the leading edge cannot route around. BULLISH, conviction MEDIUM, three years. This view was formed by MenFem's research process at Connor's request and adopted by him. The entry is the live pre-market quote on 6 November 2026.

Bull Case

Complexity keeps rising at every node and in packaging, KLA's share of equipment spend grows, and China shrinks gradually rather than suddenly.

Bear Case

What I'd have to believe for the other side: a third of revenue from China is a third of revenue at the mercy of Washington, and a record year for chip equipment is the wrong moment to underwrite three more.

Catalysts

December-quarter results (late Jan 2027)Earnings

Revenue against the $4.7B guide and the China share.

US export rulesRegulatory

Any new restriction on tool sales to China.

Risk factors

China and export controlsHigh

A third of revenue exposed to rules that can change quickly.

Equipment cycleMedium

Chip-equipment spending can fall after a peak year.

Related Calls

Key Metrics

FQ1 FY27 revenue
$4.14B
Operating margin
~45%
China share of revenue
34.5%

Weekly closes

entry 138.80

Sources

See all Semiconductors — Equipment calls